Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RBOT
stocks logo

RBOT

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-1.440
-40.74%
--
--
-1.215
-52.91%
--
--
-1.190
-46.64%
Estimates Revision
The market is revising No Change the revenue expectations for Vicarious Surgical Inc. (RBOT) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -47.28%.
EPS Estimates for FY2025
Revise Downward
down Image
-7.03%
In Past 3 Month
Stock Price
Go Down
down Image
-47.28%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Vicarious Surgical Inc (RBOT.N) is -0.60, compared to its 5-year average forward P/E of -6.02. For a more detailed relative valuation and DCF analysis to assess Vicarious Surgical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-6.02
Current PE
-0.60
Overvalued PE
2.20
Undervalued PE
-14.24

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-3.20
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
2.90
Undervalued EV/EBITDA
-9.29

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

RBOT News & Events

Events Timeline

(ET)
2025-12-03
07:10:00
Vicarious Surgical Raises 2025 Cash Burn Guidance to $45M
select
2025-11-12 (ET)
2025-11-12
16:26:15
Vicarious Surgical announces Q3 adjusted EPS of $1.91, falling short of consensus estimate of $2.33
select
2025-09-25 (ET)
2025-09-25
16:15:54
Joseph Doherty Appointed Chairman of the Board at Vicarious Surgical
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
12-04Benzinga
UiPath Shares Rise Approximately 9%; Check Out 20 Stocks Making Moves in Premarket Trading

  • UiPath Financial Results: UiPath Inc. shares rose 8.7% in pre-market trading after reporting third-quarter adjusted earnings of 16 cents per share and revenue of $411.11 million, both exceeding estimates.

  • Other Gainers: Several stocks saw significant pre-market gains, including Polyrizon Ltd (+158.1%), Nauticus Robotics, Inc (+34%), and Picard Medical, Inc (+22.3%), driven by positive news and developments.

  • Notable Losers: Virax Biolabs Group Ltd fell 16.2% after announcing a private placement, while Treasure Global Inc declined 13.3% following a reverse stock split and Nasdaq delisting notification.

  • Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies like Axogen, Inc and Hyster-Yale, Inc also experiencing notable increases.

[object Object]
Preview
7.0
12-03Businesswire
Vicarious Surgical Improves 2025 Cash Burn Guidance by $5 Million
  • Cash Burn Guidance Update: Vicarious Surgical has improved its 2025 cash burn forecast from $50 million to $45 million, reflecting ongoing cost management efforts aimed at enhancing financial health and operational efficiency.
  • Future Outlook: The company plans to provide guidance for 2026 cash burn before year-end, indicating that its ongoing operational reset will further optimize resource allocation to support long-term strategic goals.
  • Leadership Changes: The Board has appointed Victoria Carr-Brendel as Chair of the Compensation Committee, with Fuad Ahmad and Joseph Doherty joining the Compensation and Audit Committees respectively, aimed at strengthening corporate governance and decision-making efficiency.
  • Technological Innovation Context: Vicarious Surgical focuses on developing human-like surgical robots to enhance surgical efficiency and improve patient outcomes, which is expected to lower healthcare costs and enhance market competitiveness through technological breakthroughs.
[object Object]
Preview
1.0
11-20Newsfilter
Vicarious Surgical to Attend the 37th Annual Healthcare Conference Hosted by Piper Sandler

  • Company Announcement: Vicarious Surgical Inc. will participate in the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025, with a fireside discussion scheduled for 4:30 p.m. EST, accessible via a live audio webcast on their website.

  • About Vicarious Surgical: Founded in 2014, Vicarious Surgical focuses on innovative robotic technology aimed at enhancing surgical efficiency, improving patient outcomes, and lowering healthcare costs, utilizing proprietary human-like surgical robots for minimally invasive procedures.

  • Leadership and Backing: The company is led by a team of experienced professionals and has received support from notable investors, including Bill Gates and Khosla Ventures, highlighting its credibility and potential in the medical technology field.

  • Investor Communication: Vicarious Surgical intends to use its investor relations website and social media channels to disclose material information to investors, encouraging stakeholders to stay updated through these platforms alongside traditional SEC filings and press releases.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Vicarious Surgical Inc (RBOT) stock price today?

The current price of RBOT is 3 USD — it has decreased -9.09 % in the last trading day.

arrow icon

What is Vicarious Surgical Inc (RBOT)'s business?

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

arrow icon

What is the price predicton of RBOT Stock?

Wall Street analysts forecast RBOT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RBOT is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Vicarious Surgical Inc (RBOT)'s revenue for the last quarter?

Vicarious Surgical Inc revenue for the last quarter amounts to -11.50M USD, decreased -35.21 % YoY.

arrow icon

What is Vicarious Surgical Inc (RBOT)'s earnings per share (EPS) for the last quarter?

Vicarious Surgical Inc. EPS for the last quarter amounts to -10581000.00 USD, decreased -16.61 % YoY.

arrow icon

What changes have occurred in the market's expectations for Vicarious Surgical Inc (RBOT)'s fundamentals?

The market is revising No Change the revenue expectations for Vicarious Surgical Inc. (RBOT) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -47.28%.
arrow icon

How many employees does Vicarious Surgical Inc (RBOT). have?

Vicarious Surgical Inc (RBOT) has 123 emplpoyees as of December 05 2025.

arrow icon

What is Vicarious Surgical Inc (RBOT) market cap?

Today RBOT has the market capitalization of 19.64M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free